Company Filing History:
Years Active: 1991-1994
Title: Katuhisa Kojiri: Innovator in Antitumor Research
Introduction
Katuhisa Kojiri is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. With a total of 4 patents to his name, Kojiri's work has the potential to impact cancer treatment significantly.
Latest Patents
Kojiri's latest patents include the innovative Streptoverticillium ferm P-10489, which produces the antitumor agent BE-13793C. This novel substance, or a pharmaceutically acceptable salt thereof, is represented by a specific formula. The patent details an anticancer agent comprising this novel substance, along with a method for producing it and a microorganism, Streptoverticillium FERM P-10489, capable of producing the substance.
Career Highlights
Throughout his career, Kojiri has been associated with Banyu Pharmaceutical Co. Ltd., where he has focused on research and development in the pharmaceutical sector. His work has been instrumental in advancing the understanding and application of antitumor substances.
Collaborations
Kojiri has collaborated with notable colleagues, including Hiroyuki Suda and Akira Okura. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.
Conclusion
Katuhisa Kojiri's contributions to antitumor research exemplify the impact of dedicated inventors in the pharmaceutical industry. His innovative work continues to pave the way for advancements in cancer treatment.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.